Next Re SIIQ S.p.A. (BIT:NR)

Inozyme Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.8	8.19	5.74	15.06	6.85	24.92
Short-Term Investments	-	-	-	0.54	3.38	3.19
Cash & Short-Term Investments	5.8	8.19	5.74	15.6	10.22	28.11
Cash Growth	-10.44%	42.72%	-63.20%	52.60%	-63.63%	99.39%
Accounts Receivable	0.03	0.13	0.15	0.07	0.4	0.66
Other Receivables	0.83	0.15	0.22	0.59	0.83	0.65
Receivables	0.86	0.28	0.37	0.66	1.24	1.31
Prepaid Expenses	-	-	-	-	0.08	-
Other Current Assets	0.16	45.68	0.44	0.44	0.38	0.9
Total Current Assets	6.83	54.15	6.56	16.7	11.92	30.32
Property, Plant & Equipment	76.59	76.83	131.87	137.83	140.49	122.46
Other Intangible Assets	-	0.01	0.04	0.06	0.09	0.11
Long-Term Deferred Tax Assets	-	-	-	0.19	0.85	1.08
Other Long-Term Assets	1.57	1.55	2.47	2.44	2.22	1.29
Total Assets	84.99	132.54	140.93	157.22	155.57	155.27
Accounts Payable	0.27	0.35	0.65	0.84	0.89	0.89
Accrued Expenses	0.51	0.07	0.01	1.74	0.63	1.24
Short-Term Debt	-	-	-	-	-	0.04
Current Portion of Long-Term Debt	6.08	0.51	0.49	1.57	1.17	55.07
Current Income Taxes Payable	0.03	0.03	0.04	0.16	0.22	0.15
Current Unearned Revenue	0.17	0.17	-	-	-	-
Other Current Liabilities	0.21	46.93	0.86	0.17	0.11	0.36
Total Current Liabilities	7.27	48.05	2.05	4.48	3.01	57.74
Long-Term Debt	0.05	6.34	62.33	66.66	66.7	11.6
Other Long-Term Liabilities	0.05	0.04	0.04	0.1	0.17	0.31
Total Liabilities	7.4	54.45	64.44	71.31	70.07	69.9
Common Stock	63.26	63.26	63.26	63.26	63.26	63.26
Additional Paid-In Capital	22.93	22.93	22.93	22.93	22.93	22.93
Retained Earnings	-14.24	-13.45	-15.06	-5.29	-5.24	-5.44
Comprehensive Income & Other	5.64	5.35	5.35	5.01	4.54	4.61
Total Common Equity	77.59	78.1	76.49	85.91	85.5	85.37
Shareholders' Equity	77.59	78.1	76.49	85.91	85.5	85.37
Total Liabilities & Equity	84.99	132.54	140.93	157.22	155.57	155.27
Total Debt	6.13	6.84	62.82	68.23	67.87	66.71
Net Cash (Debt)	-0.33	1.35	-57.08	-52.63	-57.65	-38.6
Net Cash Per Share	-0.02	0.06	-2.60	-2.39	-2.62	-3.02
Filing Date Shares Outstanding	21.99	21.99	21.99	21.99	21.99	21.99
Total Common Shares Outstanding	21.99	21.99	21.99	21.99	21.99	21.99
Working Capital	-0.44	6.1	4.51	12.23	8.91	-27.42
Book Value Per Share	3.53	3.55	3.48	3.91	3.89	3.88
Tangible Book Value	77.59	78.08	76.45	85.85	85.41	85.26
Tangible Book Value Per Share	3.53	3.55	3.48	3.90	3.88	3.88
Buildings	1.91	1.91	-	-	-	1.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.